• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CVM:US

0.6300 USD 0.0100 1.61%

As of 20:04:03 ET on 12/26/2014.

Snapshot for CEL-SCI Corp (CVM)

Open: 0.5900 Day's Range: 0.5900 - 0.6497 Volume: 211,464
Previous Close: 0.6200 52wk Range: 0.5400 - 1.9000 1-Yr Rtn: +4.98%

Stock Chart for CVM

No chart data available.
  • CVM:US 0.6300
  • 1D
  • 1M
  • 1Y
0.6200
Interactive CVM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CVM

Current P/E Ratio (ttm) -
Estimated P/E(09/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5930
Est. EPS (USD) (09/2015) -0.3550
Est. PEG Ratio -
Market Cap (M USD) 57.55
Shares Outstanding (M) 91.35
30 Day Average Volume 285,825
Price/Book (mrq) 4.9408
Price/Sale (ttm) 130.8870
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CVM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CVM

CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer.

Maximilian De ClaraPresident/FounderGeert R KerstenCEO/Treasurer
Eyal TalorChief Scientific OfficerPatricia B PrichepSenior VP:Operations/Secy
More Company Profile & Key Executives for CVM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil